Drug Profile
ST 1141
Alternative Names: RC-1141; ST-1141Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Novo Nordisk
- Developer Helsinn Therapeutics
- Class Small molecules
- Mechanism of Action Ghrelin agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Constipation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Constipation in USA (PO)
- 04 Feb 2007 Preclinical trials in Gastrointestinal disorders in USA (PO)